Idiopathic Bilateral Simultaneous Facial Nerve Palsy (B-FNP) by Christin, Theresia et al.
Majalah Kedokteran Sriwijaya,  





Idiopathic Bilateral Simultaneous Facial  
Nerve Palsy (B-FNP) 
 
Theresia Christin1 , Ratri Wulandari1, Luther Theng2, Selly Marisdina2 
 
1Department of Neurology, RSUP DR. Mohammad Hoesin, Faculty of Medicine, 






Background: Bilateral facial nerve palsy (B-FNP) is a rare clinical manifestation with 
incidence of 1 per 5 million people. Furthermore, it approximately accounts for 0.3 – 2 % 
of facial palsy cases. This B-FNP case is intricate in the diagnosis, finding the aetiology, 
and treatment that need hospitalization.   
Case Report: A male 64-year-old with bilateral facial nerve palsy that happened suddenly 
followed by difficulty in closing both eyes and facial abnormality without clear cause within 
7 days of onset. Risk factor is hypertension stage 2.  During neurological examination, there 
was bilateral peripheral facial nerve palsy grade IV in right side and grade III in the left side 
(House Brackmann grading system) that was not followed by other cranial nerve 
abnormality and motoric examination is normal. Supporting examinations such as lumbar 
puncture, thorax photo, and head MRI with contrast shows normal result. ENMG 
examination shows absent of blink reflex. Prednisone 60 mg orally was given with tapering 
off dosage 10 mg per day. Patient was hospitalized for 12 days and was discharge with good 
clinical improvement with bilateral peripheral facial nerve paralysis grade II in right side 
and grade I in left side. 
 Conclusion: Bilateral facial nerve paralysis is a rare clinical manifestation and challenging 
in diagnosis.  It is important to have a differential diagnosis in cases with bilateral cranial 
nerve palsy. Careful physical examination and appropriate supporting examinations such as 
laboratory and radiology in necessary to evaluate the underlying cause.  
 





Facial paralysis is still a challenging clinical problem. The underlying causes range from 
life-threatening conditions to idiopathic causes that can heal on their own. Although 
unilateral facial paralysis is relatively common, reported incidence of around 20 to 25 per 
100,000 population, bilateral facial paralysis (BFP) is a rare clinical occurrence. With an 
incidence of 1 per 5 million population and are accounted for 0.3 to 2 percent of cases of 
facial paralysis. Although Bell's Palsy is the most common cause of unilateral facial 
paralysis, the etiologic factors underlying BFP are usually other medical conditions such as 
Lyme disease, Guillain Barre's Syndrome, leukemia, infectious mononucleosis, or trauma 
and require hospital treatment to diagnose and treat. 
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A 64-year-old man was treated in the neurology department of dr. Mohammad Hoesin 
Hospital Palembang with complaints of difficulty moving the face, unable to close both 
eyes, difficulty to chew food, gargle, saliva flowing from the mouth that occurs suddenly 
since 1 week ago. The patient has no history of head trauma, ear infections, joint pain, fever, 
rashes on the face or limbs. On examination vital signs are within normal limits except for 
uncontrolled hypertension which he has since 5 years ago. Blood pressure is at 150/90 
mmHg (stage 1). Head, eyes, ears, nose and throat examinations are normal. The trachea is 
not deviated, no palpable mass in the neck. There is no enlargement of the thyroid gland, 
enlarged parotid glands and adenopathy. Auscultation examination of the heart and lungs 
are within normal limits. No abnormalities on abdominal examination, no enlargement of 
organs and normal bowel sounds. 
 
Neurological examination showed bilateral peripheral facial paralysis with Grade IV on the 
right side and Grade III on the left side (House-Brackmann grading system). Tasting ability 
is still normal, and there are signs of the Bell phenomenon, flattening of nasolabial plica, 





Picture 1. Clinical Signs of Bilateral Facial Paralysis 
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Laboratory tests, including routine blood test, chemistry, and hemostasis are within normal 
limits, except lipid profile which is increased. Lumbar puncture, which is the analysis of 
CSF did not show dissociation of sitoalbumin, other parameters are within normal limits. 
Serological tests for HIV, CMV, HSV, and syphilis are negative. Unfortunately, we were 
unable to examine EBV and borrelia serology 
 
 
Picture 2. Cardiomegaly on chest X-ray 
 
Picture 3. Electrocardiogram  
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Picture 4. Coronal slice MRI of the head, T1 sequence (left), and Gadolinium (right) that 
showed no suspicious or Space Occupying lesion.  
There is a mild cerebral atrophy. Brainstem, cerebellum and CPA showed no 
abnormalities. There is no sign of sinusitis or mastoiditis. 
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Topical diagnosis of the patient can be concluded according to the course of the facial nerve 
and clinical signs that occurs. In this patient there are motor abnormalities without taste 
disturbance, hearing loss, salivary or lacrimal hyposecretion therefore the possible topical 
lesion is in the stylomastoid foramen area. Laboratory tests, including routine blood test, 
chemistry, and hemostasis are within normal limits, except lipid profile which is increased. 
Lumbar puncture, which is the analysis of CSF did not show dissociation of sitoalbumin, 
other parameters are within normal limits. Serological tests for HIV, CMV, HSV, and 
syphilis are negative. Unfortunately, we were unable to examine EBV and borrelia serology. 
Chest X-ray examination showed cardiomegaly. This is because the patient has a history of 
uncontrolled hypertension for 5 years. Contrast head MRI examination results are normal 
as well. 
 
ENMG (Electroneuromyography) examination is important in patients with Bell’s Palsy. A 
normal ENMG excludes abnormalities from Guillain Barre syndrome. Blink reflexes or 
studies on it provide useful information about the neurophysiological status of the trigeminal 
nerve and the face, brain stem, and cranial end of the cervical segment in the spinal cord, 
and show a high degree of correlation with magnetic resonance imaging (MRI) findings. 
This test is very useful in Bell's palsy patients with hemifacial spasm and synkinesis. This 
test can show hyperexitability of central motor neurons and its return to normal levels after 
recovery. This test can also show the lower quality brain function, such as the process of 
eating, prolonged blink reflex latency and amplitude decrease in peripheral facial paralysis, 
some polyneuropathies (eg, diabetes and uremic), Guillain Barre's syndrome, Behcet's 
disease, Chiari II malformations, and Wallenberg's syndrome. 
 
Although blink reflexes have been long accepted as valuable diagnostic tools, there has been 
little research on specific blink reflex parameters, that explain which specific parameters are 
useful in diagnostic and prognostic, and in what cases and when. In our clinical practice, we 
observe that peripheral facial paresis inhibits blink reflexes and that abnormalities that are 
found previously precede other clinical and neurophysiological changes. This disorder 
seems to correlate with disease outcome, or more specifically, with residual motor deficit. 
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In this case ENMG test was performed on the facial and Blink reflexes. As such, on the first 
examination, the amplitude of M. Facialis orbicularis and M. Facialis branch decreased and 
distal latency was elongated. Blink Reflex is absent from R1 and R2 Ipsilateral and R2 
Contralaterally. In needle examination, M. Frontalis has no pathological waves in 
spontaneous activity. MUAP of M.Frontalis showed decreased recruitment, amplitude and 
poor effort. After 10 days of treatment, the ENMG was re-examined. The results of M. 
Facialis orbicularis amplitude and M.Facialis branch were normal and distal latency was 
normal. This is in accordance with the clinical improvement of the patient. 
 
Bilateral facial paralysis remains a diagnostic challenge. Although the pathophysiology of 
asynchronous bilateral facial paralysis is usually associated with local inflammatory 
conditions that are believed to cause nerve ischemia (eg viral reactivation, granulomatous 
disease), the pathophysiology of synchronous bilateral facial paralysis usually involves 
more systemic problems, including neurotoxic or autoimmune processes. (eg Lyme disease, 
human immunodeficiency virus, Guillain-Barré syndrome) and major trauma (for example, 
bilateral temporal fractures). In contrast to unilateral facial paralysis, bilateral facial 
paralysis often appears as a manifestation of a serious systemic condition.2 
  
Thus, a comprehensive history and physical examination together with proper blood and 
imaging studies are needed to establish the correct diagnosis is very important. Acute 
synchronous bilateral facial paralysis that appears acutely (ie, rapidly developing paralysis) 
is often caused by trauma or infectious or autoimmune diseases (eg Lyme disease, human 
immunodeficiency virus, Guillain-Barré syndrome), whereas bilateral slow progressive 
facial paralysis is very likely to lead to neoplastic diseases such as central nervous system 
lymphoma. Diagnostic tests must include complete blood cell counts, neon treponemal 
antibody tests, human immunodeficiency virus testing, fasting glucose levels, erythrocyte 
sedimentation rates, Lyme titers, antinuclear antibody levels, antineutrophil cytoplasmic 
antibodies, antiphospholipid antibodies, and imaging with fine contrast, enhanced magnetic 
resonance imaging or computerized tomography of the temporal bone. In addition, lumbar 
puncture can be performed to evaluate cell numbers and to confirm bacterial or viral 
infections through enzyme-linked immunosorbent testing, Western blot, or polymerase 
chain reaction. Each disease has a unique initial pathophysiology, diagnosis, and treatment. 
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Bell's palsy is an acute peripheral facial nerve palsy in patients whose physical examination 
and history is unusual, consisting of deficit that affect all facial zones that equally evolved 
within 72 hours. Until now, it remains a clinical diagnosis of exclusion. Strong evidence 
shows the reactivation of herpes simplex virus type 1 in the geniculate ganglion as the 
underlying cause, with reactivation of herpes simplex virus type 1 which causes damage to 
ganglion cells, and Schwann cell infection that causes demyelination, nerve inflammation, 
and resultant ischemic compression at the level of meatal foramen. Complete recovery of 
normal facial function occurs in about 70 percent of untreated cases, with permanent facial 
dysfunction that occurs at a mild level in 13 percent and advanced in 16 percent of cases. 
Synchronous bell palsy is very rare. In the acute phase, management options for Bell palsy 
include corneal protection measures, eyelid stretching, pharmacological treatments, and 
consideration of facial neurosurgical decompression; Patients who continue to develop non-
flaccid facial paralysis may be offered physical therapy, chemodenervation. 
 
The final diagnosis in these patients can be concluded with a bilateral Bell's palsy 
(idiopathic) by getting rid of several differential diagnoses from B-FNP. After 12 days of 
treatment the patient returned home in good condition, almost completely healed, namely 
with bilateral peripheral Grade II facial paralysis on the right side and Grade I on the left 
side (House-Brackmann grading system). During treatment the patient only received 
neurotonic which is the injection of 500uq mecobalamin every 8 hours and corticosteroid 
which is 5 mg tablet of prednisone. Administration of prednison at a dose of 1 mg / kg / day 
with a maximum of 60 mg / day and is reduced every 5 days at 10 mg increments. There are 
two studies that use prednisone in the treatment of Bell’s palsy. 
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The first study conducted by Engstrom et al (2008) used an oral prednisone dose of 60 mg 
/ day for 5 days, then reduced by 10 mg daily, with a total treatment time of 10 days. The 
drug is given within 72 hours after onset. Bell’s palsy. Follow up was carried out between 
days 11-17, and at 1,2,3,6,12 months after randomization by assessing facial nerve function 
using the House-Brackmann (HB) grading system. The result showed that patients who 
received prednisone had shorter time to complete recovery and a better outcome after 12 
months (fewer synkinesia events) than patients who did not get prednisone.  
  
Another study was carried out by Sullivan et al (2007) who used prednisone at a dose of 25 
mg twice daily for 10 days given within 72 hours after onset. Assessment of facial nerve 
function using the HB grading system. This study showed that patients who were given 
prednisone had better outcomes with complete cure of 90% patients treated with prednisone 
and 75% in patients who did not get prednisolone. In this case antivirals were not given 
because the patient came on day 7. The possibility of HSV-1 in the etiology of Bell's palsy 
has been considered but in this case the blood serology results on HSV-1 are still within 
normal limits.  
Although the 2004 Cochrane review found insufficient evidence to support the use of this 
antivirus alone7, two recent placebo-controlled trials showed full recovery in a higher 
percentage from patients treated with antiviral drugs combined with prednisolone rather 
than prednisolone alone. (100 percent versus 91 percent and 95 percent versus 90 percent) 
.8,9 However, no observed benefit was seen when treatment was delayed for more than four 
days after symptom onset. (86 percent versus 87 percent) .9. The role of physiotherapy is 




Picture 5. ENMG result that fits the image of demyelinating peripheral neuropathy 
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Picture 6. Clinical Improvement of the patient 
 
CONCLUSION 
Unilateral facial paralysis is usually idiopathic or associated with viral disease. On the other 
hand, bilateral facial nerve palsy is a rare and diagnostic challenge. Emergency physicians 
must be aware of various diagnostic possibilities, some of which are life-threatening and 
potentially fatal. We emphasize the importance of considering differential diagnoses in all 
cases accompanied by bilateral facial nerve palsy. These patients require careful assessment 
and examination and proper laboratory and radiological examinations for evaluation of the 
underlying cause and further relevant management. Thus, our bilateral FNP case, that 
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